Sirna Therapeutics' IPO

Sirna Therapeutics raised a round of funding on September 09, 2003. Investors include Public.

Sirna Therapeutics develops treatments based on RNAi technology for asthma, diabetes, hepatitis C, macular degeneration and Huntington's Disease.…

Articles about Sirna Therapeutics' IPO: